Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23.
Article PubMed PubMed Central Google Scholar
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Stat 2022 CA: Cancer J Clin. 2022;72(6):524–41.
Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi S-M, Balouchi A. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;176:519–33.
Ho SS, So WK, Leung DY, Lai ET, Chan CW. Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. Eur J Oncol Nurs. 2013;17(6):877–82.
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30(2):112–26.
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330(7493):702.
Article PubMed PubMed Central Google Scholar
Zhu G, Li J, Li J, Wang X, Dai M, Chen J. Depression and survival of breast cancer patients: A protocol for systematic review and meta-analysis. Med (Baltim). 2020;99(48):e23399.
Manning M, Bettencourt BA. Depression and medication adherence among breast cancer survivors: bridging the gap with the theory of planned behaviour. Psychol Health. 2011;26(9):1173–87.
Avis NE, Levine B, Naughton MJ, Case LD, Naftalis E, Van Zee KJ. Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat. 2013;139(1):199–206.
Christensen S, Zachariae R, Jensen AB, Vaeth M, Møller S, Ravnsbaek J, et al. Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat. 2009;113(2):339–55.
Charles C, Bardet A, Larive A, Gorwood P, Ramoz N, Thomas E, et al. Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France. JAMA Netw Open. 2022;5(4):e225118.
Article PubMed PubMed Central Google Scholar
Chang CH, Chen SJ, Liu CY. Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. J Affect Disord. 2015;182:44–9.
Article CAS PubMed Google Scholar
Suppli NP, Johansen C, Christensen J, Kessing LV, Kroman N, Dalton SO. Increased Risk for Depression After Breast Cancer: A Nationwide Population-Based Cohort Study of Associated Factors in Denmark, 1998–2011. J Clin Oncol. 2014;32(34):3831–9.
Nakamura ZM, Deal AM, Nyrop KA, Chen YT, Quillen LJ, Brenizer T, et al. Serial Assessment of Depression and Anxiety by Patients and Providers in Women Receiving Chemotherapy for Early Breast Cancer. Oncologist. 2020;26(2):147–56.
Article PubMed PubMed Central Google Scholar
Hwang SY, Chang SJ, Park BW. Does chemotherapy really affect the quality of life of women with breast cancer? J Breast Cancer. 2013;16(2):229–35.
Article PubMed PubMed Central Google Scholar
Cathcart CK, Jones SE, Pumroy CS, Peters GN, Knox SM, Cheek JH. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 1993;27(3):277–81.
Article CAS PubMed Google Scholar
Lee KC, Ray GT, Hunkeler EM, Finley PR. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics. 2007;48(3):205–10.
Choi HL, Kim B, Han K, Shin DW. Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea. American Society of Clinical Oncology; 2024.
Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med. 2022;6(1):9–31.
Seo HJ, Oh IH, Yoon SJ. A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev. 2012;13(12):6163–8.
Choi HL, Ahn JH, Chang WH, Jung W, Kim BS, Han K, et al. Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea. Eur J Neurol. 2024;31(4):e16194.
Article PubMed PubMed Central Google Scholar
Park Y-MM, Jung W, Yeo Y, Park SH, Fradley MG, Malapati SJ, et al. Mid- and long-term risk of atrial fibrillation among breast cancer surgery survivors. BMC Med. 2024;22(1):88.
Article PubMed PubMed Central Google Scholar
Hwang S, Kang SW, Kim SJ, Han K, Kim BS, Jung W et al. Impact of Age-Related Macular Degeneration and Related Visual Disability on the Risk of Depression: A Nationwide Cohort Study. Ophthalmology 2023,130(6):615–623.
Kwon S, Han KD, Kim B, Jung W, Chang WH, Jeon HJ et al. Increased risk of developing depression in disability after spinal cord injury: A nationwide cohort study in South Korea. Gen Hosp Psychiatry 2024.
Pescatello LSRD, Thompson PD. ACSM’s Guidelines for Exercise Testing and Prescription 9th Ed. Lippincott Williams & Wilkins; 2014.
Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc. 1999;94(446):496–509.
Park CY, Lim JY, Park HY. Age at natural menopause in Koreans: secular trends and influences thereon. Menopause. 2018;25(4):423–9.
Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011;4(3):363–71.
Krebber AM, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 2014,23(2):121–130.
Cohee AA, Stump T, Adams RN, Johns SA, Von Ah D, Zoppi K, et al. Factors associated with depressive symptoms in young long-term breast cancer survivors. Qual Life Res. 2016;25(8):1991–7.
Article PubMed PubMed Central Google Scholar
Mertz BG, Bistrup PE, Johansen C, Dalton SO, Deltour I, Kehlet H, et al. Psychological distress among women with newly diagnosed breast cancer. Eur J Oncol Nurs. 2012;16(4):439–43.
Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Netw Open. 2024;7(1):e2353331–2353331.
Article PubMed PubMed Central Google Scholar
Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: Results from the UK Standardisation of Radiotherapy Trials (START). Breast. 2010;19(2):84–91.
Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184–93.
Bloom JR, Stewart SL, Chang S, Banks PJ. Then and now: quality of life of young breast cancer survivors. Psychooncology. 2004;13(3):147–60.
Doan LV, Yoon J, Chun J, Perez R, Wang J. Pain associated with breast cancer: etiologies and therapies. Front Pain Res 2023,4.
Shabangu N, Thebe T, Casey M, Wesselmann U, Parker R. Chronic pain in female breast cancer survivors - prevalence, characteristics and contributing factors: a cross-sectional pilot study. BMC Womens Health. 2023;23(1):613.
Article PubMed PubMed Central Google Scholar
Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29(1):e18–20.
留言 (0)